<DOC>
	<DOCNO>NCT01677299</DOCNO>
	<brief_summary>This study evaluate EFB0027 EFB0026 behave subject type 2 diabetes mellitus . In addition , study compare effect EFB0027 EFB0026 circulate concentration glucose gastrointestinal hormone subject type 2 diabetes mellitus .</brief_summary>
	<brief_title>Assessing PK Effect Glucose GI Hormone Concentrations Metformin Delayed-Release Subjects With T2DM</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>1 . Is 19 70 ( inclusive ) year old Visit 1 ( Screening ) . 2 . Is diagnosed Type 2 Diabetes Mellitus HbA1c 6.0 9.5 % ( inclusive ) subject manage diabetes : . Diet exercise alone , ii . A stable regimen ( minimum 2 month Visit 1 ) metformin alone , iii . A stable regimen ( minimum 2 month Visit 1 ) DPP4 inhibitor alone , OR HbA1c 6.0 8.5 % ( inclusive ) subject manage diabetes stable ( minimum 2 month Visit 1 ) combination regimen metformin DPP4 inhibitor . 3 . Has serum creatinine upper limit normal Visit 1 estimate creatinine clearance 80 use Crockroft Gault equation ( CrCl = [ ( 140 age ) x body weight kg ] / ( serum creatinine x 72 ) x ( 0.85 female ) [ ref . 3 ] . 4 . Has body mass index ( BMI ) 25.0 40.0 kg/m^2 ( inclusive ) Screening . 5 . Is male , female meet follow criterion : Not breastfeed Negative pregnancy test result ( human chorionic gonadotropin , beta subunit ) Visit 1 ( Screening ) ( applicable hysterectomized female ) Surgically sterile , postmenopausal , childbearing potential , must practice willing continue practice appropriate birth control entire duration study 6 . Has physical examination clinically significant abnormality judge investigator . 7 . Ability understand willingness adhere protocol requirement . 8 . If chronic thyroid pharmacologic therapy , dose must stable least 3 month prior Visit 1 ( Screening ) , must thyroidstimulating hormone ( TSH ) test result normal range Visit 1 ( Screening ) . 1 . Has clinically significant medical condition could potentially affect study participation and/or personal wellbeing , judge investigator , include limited following condition : Hepatic disease Renal disease Gastrointestinal disease Endocrine disorder except diabetes Cardiovascular disease Seizure disorder Organ transplantation Chronic infection 2 . Has chronic disease require medication adjust past 90 day ( subject may take acute intermittent overthecounter medication Tylenol , need ) . 3 . Has drug treatment affect gastric pH ( prescription overthecounter ) , include antacid medication Rolaids Pepcid within 2 day Visit 1 ( Screening ) . 4 . Has major surgery kind within 6 month Visit 1 ( Screening ) . 5 . Has receive blood transfusion within 6 month Visit 1 ( Screening ) . 6 . Has history &gt; 5 kg weight change within 3 month Visit 1 ( Screening ) . 7 . Has clinical laboratory test ( clinical chemistry , hematology , urinalysis ) abnormality expect subject diabetes judged investigator clinically significant Visit 1 ( Screening ) . 8 . Has physical , psychological , historical finding , investigator 's opinion , would make subject unsuitable study . 9 . Currently abuse drug alcohol history abuse investigator 's opinion would cause individual noncompliant study procedure . 10 . Has donate blood within 2 month Visit 1 ( Screening ) plan donate blood study . 11 . Has use insulin within 3 month Visit 1 ( Screening ) . 12 . Has receive GLP1 receptor agonist and/or thiazolidinedione treatment within 6 month Visit 1 ( Screening ) . 13 . Has know intolerance metformin . 14 . Has receive investigational drug within 1 month ( five halflives investigational drug , whichever great ) Visit 1 ( Screening ) . 15 . Has know allergy hypersensitivity component study treatment . 16 . Is employed Elcelyx Therapeutics , Inc ( employee , temporary contract worker , designee company ) . 17 . Smokes 10 cigarette per day , 2 cigar per day , use 1 smokeless tobacco per week .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>